0:0020:05

Healthcare Leaders: Leveraging Data, Emerging MedTech & Collaboration to Meet the Needs of Underserved Communities

Arthi Chandran 20:05 2023

Trials that approve medical products still leave patients of color out

In 2011, African Americans and Hispanic Americans made up 16 and 12 percent of the US population but only 1 and 5 percent of clinical trial patients. Arthi Chandran, a chronic disease epidemiologist leading health economics and reimbursement at Abbott Medical Devices, argues this gap shapes who actually benefits from new technology. If genes do not separate us, what is really driving unequal outcomes, and what can healthcare leaders change?

Learn where trial and design gaps start and the practical steps leaders can take to close them

Watch on YouTube

In short

Arthi Chandran, chronic disease epidemiologist and head of health economics and reimbursement at Abbott Medical Devices, argues that healthcare inequity is driven by social determinants of health rather than biology, and that unrepresentative clinical trials hide how well technologies serve everyone. She outlines practical ways to remove barriers to trial participation, use real-world evidence and patient advocacy, and plan beyond product design so innovations reach underserved communities.

“So I'd like to start today by honoring the fact that we are more similar than we are different.”
“I think we have to know that we can't always solve for inequity using a design of a technology.”

What you will learn

  • Explain how social determinants of health, rather than genetics, drive disparities in chronic disease and outcomes.
  • Spot the trial design choices, such as insurance-linked costs and strict protocols, that exclude disadvantaged patients.
  • Apply practical tactics to diversify study participation, from transportation and home visits to trusted community partners.
  • Use real-world evidence and patient advocacy to check whether technologies deliver intended outcomes after launch.
  • Plan support beyond the product itself and discuss bias openly as part of continuous improvement.

Key takeaways from the speaker

  • Solutions to ensure medical devices and products are designed to support the needs of every person.
  • Cross-collaboration strategies with payers, providers, stakeholders, regulatory and the healthcare system to have a deeper engagement with clinical teams.
  • Best practices to develop a deeper engagement with clinical teams to meet your stakeholder’s needs.

Details

Level
Beginner
Format
Talk
Technical depth
Non-technical
For
All career stages
Length
20:05
Published
June 2023

Questions this talk answers

If race is not biological, what explains healthcare disparities between racial groups?

Chandran points to social determinants of health: where people live and work, education, access to healthy food, social support, culture and how they engage with the healthcare system. These are shaped by policy and society and create systemic inequality that disproportionately affects communities of color.

Why are women and people of color underrepresented in medical device trials?

Study costs are often shared by Medicare or commercial insurance, which favors insured patients, and strict protocols exclude people with inflexible work schedules, no caregiver support or no transportation.

How can companies make clinical trials more representative?

By removing access barriers, for example providing transportation, bringing care to patients' homes, improving health literacy, and working with trusted community institutions such as churches, nail salons and barbershops.

What should happen after a technology reaches the market?

Teams should keep learning through real-world evidence, give patients a voice through advocacy, and partner so that asking and investing in these questions becomes the norm.

Can good product design alone solve healthcare inequity?

No. Chandran says design must be paired with plans to do more beyond the product so it actually serves the intended communities.

About this talk

Healthcare products and medical technology are designed to diagnose, treat and support adherence to post-intervention care, ultimately changing the trajectory of one’s health and life experience. To increase affordability and accessibility, healthcare innovations must be backed by data to ensure products support every person. A cross-collaborative approach between clinical teams, researchers, regulatory and stakeholders is essential to satisfy and enhance patient outcomes.

With over 15 years in the healthcare industry, Arthi Chandran designs pathways to success for patients by working with the government, healthcare decision-makers and payers/providers to ensure technology is available to every patient. Using research and evidence-based insights, Arthi articulates the unmet needs of patients to help design services and products to support equity and access.

During the session, Arthi will expand upon how healthcare leaders can better collaborate to ensure data and research drive innovation and healthcare solutions. This will ultimately help create a more equitable healthcare ecosystem ensuring products are designed and available to every community.

Topics

Related talks

Browse the library